Campath 1 H "in the bag" is an effective method of GvHD prevention in allogeneic stem cell transplantation.

Campath 1 H "in the bag" is an effective method of GvHD prevention in allogeneic stem cell transplantation.

Библиографические подробности
Главные авторы:	Potter, M, Grace, S, Teehan, C, Ethell, M, Theocharous, P, Claude, R, Hale, G, Waldmann, H, Prentice, H
Формат:	Journal article
Опубликовано:	2000

Схожие документы

Addition of cyclosporin post transplantation decreases GvHD without enhancing the adverse effect of T-cell depletion with CAMPATH-1H "in the bag": The cape town experience
по: Novitzky, N, и др.
Опубликовано: (2003)

In vivo CAMPATH-1H prevents GvHD following nonmyeloablative stem-cell transplantation.
по: Kottaridis, P, и др.
Опубликовано: (2001)

Bone marrow GvHD after allogeneic hematopoietic stem cell transplantation
по: Martin eSzyska, и др.
Опубликовано: (2016-03-01)

Cellular Strategies for Separating GvHD from GvL in Haploidentical Transplantation
по: Mauro Di Ianni, и др.
Опубликовано: (2024-01-01)

COMBINED USE OF CAMPATH-1G IN-VIVO AND IN THE BAG IN ALLOGENEIC BONE-MARROW TRANSPLANTATION
по: Fibbe, W, и др.
Опубликовано: (1993)

The Role of Bacteria and Pattern Recognition Receptors in GvHD
по: E. Holler, и др.
Опубликовано: (2010-01-01)

Galectin-3 expression in donor T cells reduces GvHD severity and lethality after allogeneic hematopoietic cell transplantation
по: Hemn Mohammadpour, и др.
Опубликовано: (2023-03-01)

T cell depletion with CAMPATH-1 in allogeneic bone marrow transplantation.
по: Hale, G, и др.
Опубликовано: (1988)

Recent results using CAMPATH-1 antibodies to control GVHD and graft rejection.
по: Hale, G, и др.
Опубликовано: (1996)

In marrow aplasia reduced-intensity conditioning and T-cell depletion of cytokine mobilised stem cells provides good engraftment without GvHD
по: Novitzky, N, и др.
Опубликовано: (2006)

Allogeneic DNT cell therapy synergizes with T cells to promote anti-leukemic activities while suppressing GvHD
по: Jongbok Lee, и др.
Опубликовано: (2025-01-01)

Modulation of T-regulatory cells by small molecules: potential therapy for GvHD
по: Leuschner, U
Опубликовано: (2021)

Immunometabolic Therapeutic Targets of Graft-versus-Host Disease (GvHD)
по: Kudakwashe Mhandire, и др.
Опубликовано: (2021-10-01)

Effective Extracorporeal Photopheresis of Patients with Transplantation Induced Acute Intestinal GvHD and Bronchiolitis Obliterans Syndrome
по: Robin Reschke, и др.
Опубликовано: (2022-08-01)

The role of animal models in the study of hematopoietic stem cell transplantation and GvHD: A historical overview.
по: Margherita Boieri, и др.
Опубликовано: (2016-08-01)

Effect of the YCD3-1 Anti-Mouse Monoclonal on Murine GvHD
по: James P. Okunewick, и др.
Опубликовано: (1993-07-01)

Quality of life of patients with graft-versus-host disease (GvHD) post-hematopoietic stem cell transplantation
по: Sibéli de Fátima Ferraz Simão Proença, и др.

The Relationship between STR-PCR Chimerism Analysis and Chronic GvHD following Hematopoietic Stem Cell Transplantation
по: Seyed Asadollah Mousavi, и др.
Опубликовано: (2016-12-01)

Extracorporeal photopheresis as an immunomodulatory treatment modality for chronic GvHD and the importance of emerging biomarkers
по: Ines Bojanic, и др.
Опубликовано: (2023-02-01)

Antigen-specific priming is dispensable in depletion of apoptosis-sensitive T cells for GvHD prophylaxis
по: Shai eYarkoni, и др.
Опубликовано: (2014-05-01)

Alemtuzumab (Campath-1H) in allogeneic stem cell transplantation: where do we go from here?
по: Chakrabarti, S, и др.
Опубликовано: (2004)

HLA and Non-HLA Factors for Donor Selection in Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide GvHD Prophylaxis
по: Hiroko Shike, и др.
Опубликовано: (2024-12-01)

Campath-1 Abs 'in the bag' for hematological malignancies: the Cape Town experience.
по: Novitzky, N, и др.
Опубликовано: (2004)

INVITRO TREATMENT OF MARROW WITH ATCG OR CAMPATH-1 FOR PROPHYLAXIS OF GVHD - RESULTS OF THE AG-KMT MUNCHEN
по: Kolb, H, и др.
Опубликовано: (1985)

HSCT with Mismatched Unrelated Donors (MMUD): A Comparison of Different Platforms for GvHD Prophylaxis
по: Massimo Berger, и др.
Опубликовано: (2022-02-01)

Spontaneous xenogeneic GvHD in Wilms' tumor Patient‐Derived xenograft models and potential solutions
по: Seyed Mostafa Monzavi, и др.
Опубликовано: (2022-08-01)

Correction to: Tregs and GvHD prevention by extracorporeal photopheresis: observations from a clinical trial
по: Roberto Crocchiolo, и др.
Опубликовано: (2021-03-01)

CAMPATH-1 antibodies in stem-cell transplantation.
по: Hale, G, и др.
Опубликовано: (2001)

Accumulation of T-cell-suppressive PD-L1high extracellular vesicles is associated with GvHD and might impact GvL efficacy
по: Regina Jitschin, и др.
Опубликовано: (2023-03-01)

Availability of Campath-1 antibodies for bone marrow transplantation.
по: Hale, G, и др.
Опубликовано: (1995)

CAMPATH-1 monoclonal antibodies in bone marrow transplantation.
по: Hale, G, и др.
Опубликовано: (1994)

Impaired thymic iNKT cell differentiation at early precursor stage in murine haploidentical bone marrow transplantation with GvHD
по: Weijia Zhao, и др.
Опубликовано: (2023-08-01)

Fibroblastic reticular cells mitigate acute GvHD via MHCII-dependent maintenance of regulatory T cells
по: Haroon Shaikh, и др.
Опубликовано: (2022-11-01)

FTY720 ameliorates GvHD by blocking T lymphocyte migration to target organs and by skin fibrosis inhibition
по: Jaeyoon Ryu, и др.
Опубликовано: (2020-06-01)

3120 Probable multifocal central nervous system graft-versus-host disease (CNS GvHD) with concurrent cerebellitis following allogenic stem-cell transplant (ASCT) for T-cell leukemia
по: Deepti Dr Yagnik
Опубликовано: (2024-08-01)

Evaluation of non-myeloablative conditioning combining beam with in vivo pre-transplant Campath-IG for allogeneic transplantation in patients with lymphoma.
по: Russell, N, и др.
Опубликовано: (1999)

IL-10 mRNA Engineered MSCs Demonstrate Enhanced Anti-Inflammation in an Acute GvHD Model
по: Cuiping Zhang, и др.
Опубликовано: (2021-11-01)

GPR Expression in Intestinal Biopsies From SCT Patients Is Upregulated in GvHD and Is Suppressed by Broad-Spectrum Antibiotics
по: Sakhila Ghimire, и др.
Опубликовано: (2021-10-01)

Sirolimus-Based Immunosuppression as GvHD Prophylaxis after Bone Marrow Transplantation for Severe Aplastic Anaemia: A Case Report and Review of the Literature
по: Katia Perruccio, и др.
Опубликовано: (2015-01-01)

Off-the-shelf third-party HSC-engineered iNKT cells for ameliorating GvHD while preserving GvL effect in the treatment of blood cancers
по: Yan-Ruide Li, и др.
Опубликовано: (2022-09-01)